Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

by Penner, Iris-Katharina, Stemper, Brigitte, Calabrese, Pasquale, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalbán, Xavier, Barkhof, Frederik, Pleimes, Dirk, Lanius, Vivian, Pohl, Christoph, Kappos, Ludwig, Sandbrink, Rupert
Published 2012

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

by Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Published 2016

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

by Hartung, Hans-Peter, Kappos, Ludwig, Goodin, Douglas S., O’Connor, Paul, Filippi, Massimo, Arnason, Barry, Comi, Giancarlo, Cook, Stuart, Jeffery, Douglas, Petkau, John, White, Richard, Bogumil, Timon, Beckmann, Karola, Stemper, Brigitte, Suarez, Gustavo, Sandbrink, Rupert, Pohl, Christoph
Published 2015

Molecular mechanism underlying the impact of vitamin D on disease activity of MS

by Munger, Kassandra L, Köchert, Karl, Simon, Kelly C, Kappos, Ludwig, Polman, Chris H, Freedman, Mark S, Hartung, Hans P, Miller, David H, Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Pleimes, Dirk, Sandbrink, Rupert, Ascherio, Alberto, Pohl, Christoph
Published 2014

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

by Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry GW, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim
Published 2012